This author has yet to write their bio.Meanwhile lets just say that we are proud IDEAL contributed a whooping 60 entries.
IDeAl coordinator Prof. Ralf-Dieter Hilgers gives a talk on Friday, 22nd of April, at George Mason University in Fairfax, Virginia, USA. In his talk, Ralf-Dieter Hilgers, will advocate that a scientific evaluation must precede the choice of a randomization procedure, analogously to e.g. sample size calculation. He gives a framework for the clinical scenario evaluation of […]
Coordinator Ralf-Dieter Hilgers and Nicole Heussen give a talk at the U.S. Food and Drug Administration on 2016 May 6 titled “Does Randomization protect against bias? What can be done to improve the level of clinical evidence of effectiveness?”. In their talk, they share new findings on small population group methodology and connect them with […]
IDeAl senior researcher Nicole Heussen and IDeAl coordinator Ralf-Dieter Hilgers disseminate IDeAl methodology to stakeholders from regulators to academia in the United States. During their three week stay in April 2016, they present their latest results at U.S. Food and Drug Administration (FDA) and give IDeAl input to FDAs guidelines. Furthermore, during their stay, they […]
Several researchers connected to the IDeAl group present their research at the Fourth Joint Statistical Meeting of the Deutsche Arbeitsgemeinschaft Statistik “Statistics under one Umbrella” that takes place at Georg-August University Göttingen this week (14th- 18th of March). Rosemary Bailey (EAB) talks about “Design of Dose-Escalation Trials”, presenting her “Research Spurred by a Trial That […]
On behalf of the IDEAL consortium Franz König will give an invited tutorial on „Adaptive Designs for Confirmatory Clinical Trials” at the ENAR 2016 Spring Meeting in Austin, Texas, on March 8. The meeting is organized by Eastern North American Region (ENAR) of the International Biometric Society (IBS). A recent review by Elsaeßer et al […]
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
OKBy continuing to use the site, you agree to the use of cookies. more information